LinkedIn image ad examples

qEV Gen 2 columns deliver higher EV recovery and purity than comparable CL-4B and CL-2B columns. The exclusive resin formulation has been designed specifically for extracellular vesicle separation. Read our full comparison to learn more.

Vi vet att du har mycket på jobbet. Transcribe underlättar din vardag. Konvertera röstmeddelanden automatiskt till text i Aurora teleQ. Administrationstiden går ner – och du får mer tid till dina patienter. Nu har Transcribe ännu högre träffsäkerhet på läkemedelsnamn. Ytterligare ett steg mot en smidigare arbetsdag.

Hur många röstmeddelanden lyssnar du på varje dag? 👀 Spara tid, och få en snabb överblick med Transcribe. Låt dina röstmeddelanden tryggt transkriberas med hjälp av AI inom Aurora teleQ. För en smidigare och effektivare arbetsdag.

How does your organisation’s readiness compare to peers who faced the 2026 Middle East conflict? This whitepaper shares survey-based findings on travel disruption, workforce safety, supply chain impact and business continuity. Benchmark your current capabilities and discover how to prioritise the improvements that matter most.

Travel disruption and employee safety were top concerns for leaders in 2026. Discover key findings and actionable steps to protect your workforce.

Imagine your next breakthrough starting with a patient’s story, not a Petri dish. When you bring human-relevant biology, translational science and clinic-informed discovery into the same conversation, you don’t just move a candidate forward, you give it a fighting chance to matter in real lives. Join Roche and IQVIA Laboratories on November 19 to explore how you can prioritize the right candidates, reduce painful late-stage failures and feel confident that your early decisions truly serve future patients. Register now: https://hubs.ly/Q04BrWNX0

When your discovery decisions are guided by clinical endpoints from day one, every experiment works harder for you. By grounding your work in human-relevant biology, translational science and clinic-informed discovery, you can prioritize candidates with clearer evidence, cut avoidable risk and shorten the path from idea to patient impact. Join Roche and IQVIA Laboratories on November 19 to see practical ways you can make your pipeline more predictable, more efficient and more clinically meaningful. Register now: https://hubs.ly/Q04BrWNX0

Imagine healthcare where you actually know your doctor—and they know you. At Complete Concierge Care’s “Do I Need a Concierge Doctor?” event you’ll hear how our concierge model supports deeper relationships, physician‑led preventive care, and easier access. Ask your questions and see whether this approach fits your needs.

Concierge medicine gets talked about more than it gets explained. So we’re setting aside time to do exactly that. Join our physicians for an informal info session on how the model works, what membership includes, and what it’s like to have a primary care doctor who actually has time for you — small panels, direct access, same or next-day visits, and a real person every time you call. Two ways to join: In person: Wednesday, November 4, 5–7 PM · Hunter’s Bar and Grill, Potomac, MD Virtual: Tuesday, November 17, 6 PM · link sent after RSVP Same material at both. Come with questions.

بيئة عمل أفضل تبدأ بموظفين يحظون بالدعم النفسي. عرب ثيرابي تساعد شركتكم على الاستثمار في صحة موظفيها النفسية تواصلو معنا واكتشفوا برامجنا للشركات

EEG looks simple in a protocol. In practice, it needs a site, a technician, and a participant who can travel, often at every time point. NeuroJournal moves EEG recording home, so your visit schedule can follow the science instead of site capacity. Keep in-clinic recordings where you need them; go remote where you don't.

Two or three in-clinic EEG recordings don't show what happened in between the visits. NeuroJournal captures EEG and cognitive measures repeatedly across your trial, at home and in the clinic, giving your digital endpoint team a denser longitudinal record to work with.

Claimable uses AI to help patients generate stronger, faster appeals, giving pharma teams a scalable way to reduce abandonment and restore access.

أكثر من 500 مختبر يعتمد على Erba LIMS لإدارة سير العمل اليومي. من استلام العينة إلى اعتماد التقرير، كل خطوة واضحة وموثّقة في منصة واحدة: ✔ تتبّع دقيق للعينات ✔ زمن إنجاز أسرع ✔ أخطاء أقل ✔ امتثال أسهل لمعايير CAP و ISO 15189 احجز عرضك التجريبي واكتشف كيف يعمل مختبرك بكفاءة أعلى.

«أين وصلت تلك العينة؟» سؤال لا ينبغي أن يستغرق أكثر من ثوانٍ. عندما تتوزع معلومات العينات على خطوات وأنظمة مختلفة، تصبح الرؤية الواضحة أصعب مما ينبغي. يمنحك Erba LIMS متابعة لحظية لكل عينة: تم الاستلام، قيد التحليل، بانتظار المراجعة، مكتمل. احجز عرضك التجريبي وشاهد ذلك بنفسك.

The physician shortage is expected to approach 140,000 by 2036, making locum tenens essential to maintaining coverage and keeping patient care on track. Hallmark centralizes locums administration with a vendor-neutral platform that connects agencies, providers, credentialing status, onboarding, compliance, and financial oversight in one place. Standardized workflows improve visibility, reduce administrative burden, and create a single source of truth across your locums program.

Seeing risk signals isn’t enough. Learn how leading CROs connect risk, decisions, and action to deliver inspection-ready RBQM at scale.

Reminder: Live Flash Talk this Thursday👇 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗧𝗮𝗰𝗸𝗹𝗲 𝗧𝗼𝘂𝗴𝗵 𝗧𝗮𝗿𝗴𝗲𝘁𝘀 🗓️ Thursday, Oct. 22th ⏰ 8 AM PT | 11 AM ET | 5 PM CET Drug discovery is increasingly focused on biological targets once considered undruggable. In this difficult-to-drug space, success depends on understanding how the target should be modulated, identifying molecules capable of delivering the desired mechanism, and rapidly establishing confidence in their activity. In this Flash Talk, Andrea Weston, Head of Discovery Biology and Pharmacology at Pfizer, will explore how the thoughtful integration of platform technologies can improve the probability of success against challenging targets. She will highlight how the right protein reagents and cellular models can be critical to successful lead identification, and how defining the desired mechanism of action before screening can better position programs for success. Andrea will also examine current hit-finding strategies and emerging approaches for elucidating small-molecule MoAs, sharing how these advances are collectively expanding the boundaries of druggability and creating new opportunities to discover transformative medicines. 🔗 Register now to learn more about recent advances in platform technologies and their applications towards difficult-to-drug targets: https://lnkd.in/gqu4pPBZ #DrugDiscovery #MedicinalChemistry #SmallMolecule #HitFinding #LeadDiscovery

🔴 𝗔 𝗰𝗮𝗹𝗹 𝘁𝗼 𝗮𝗰𝘁𝗶𝗼𝗻 𝗮𝘁 𝗮 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗺𝗼𝗺𝗲𝗻𝘁 𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗴𝗵𝘁 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗛𝗜𝗩/𝗔𝗜𝗗𝗦 Former presidents, prime ministers and public health leaders, have signed a joint statement urging governments to renew their commitment to the HIV response. Their call: prioritise HIV, expand access to prevention, testing and treatment, and support people living with HIV to remain in care. This call also matters for #Europe, where HIV must remain a political and funding priority. Read the joint statement in The Brussels Times: https://lnkd.in/ePbM2cHH 📷 Keep the Promise march at the International AIDS Conference in Washington, D.C., July 2012. #AIDSIsNotOver #HIV #GlobalHealth AIDS Healthcare Foundation | AHF Asia | AHF Global Public Health Institute | AIDS Healthcare Foundation Africa | Club de Madrid | DG SANTE | European Commission Kim Campbell | Laura Chinchilla Miranda | Alfred Gusenbauer | tarja halonen | Han Seun-soo | Stefan Löfven | James Alix Michel | Jigmi Yoser Thinley | Danilo Türk | Leo Varadkar | María Elena Agüero | Michael Weinstein | Dr.Penninah Iutung | Jorge Saavedra

Backed with $31.7M to predict drug safety in silico — and cut the industry's reliance on animal testing.

Should a pharmaceutical company invest in a dedicated statistical methodology group? On this week's "In the Interim…", Scott Berry talks with Jenny Devenport and Kaspar Rufibach of Merck Group, co-authors of the paper "Statistical Methodology Groups in the Pharmaceutical Industry," and May Mo of Amgen, a co-author of a US commentary on it. Highlights from the conversation: ✅️ Why a new method adds little until it is published, built into software, and scaled ✅️ How new mechanisms of action are pushing trial design beyond the t-test and log-rank test ✅️ Keeping methodologists and project statisticians working as one team ✅️ How one better phase 3 decision can pay for a methods group ✅️ Giving leadership design options, risks, and trade-offs instead of a single answer The full episode is live now: https://lnkd.in/gdUD5rJT

Turn RBQM into a growth engine. Get the blueprint for stronger sponsor confidence, smarter CRA deployment, and more predictable delivery.

A 30.6% hit rate across 80B compounds. Binding poses predicted to 1.2Å before the crystal structure existed. Outperforming AlphaFold3, Boltz-1 and Chai-1 on novel targets.

When your child struggles in school, understanding why can make a difference. Our expert educational assessments offer individualized insights to help guide support at home, in the classroom, and beyond. At Family Care Center, we offer: • Short wait times • Independent, thorough evaluations • Clear recommendations • Flexible payment options Learn how our testing can bring clarity and confidence to your child’s educational journey: https://hubs.ly/Q04zS4Y00 #FamilyCareCenter #PsychoeducationalTesting #EducationalAssessments #LearningSupport #StudentSuccess